Skip to content

普里维亚健康

US · PRVA #2604 按市值排名 上市于 2021
22.52 -0.10 -0.44%
实时 - 追踪5344个代码 - 心跳于137秒前 · 2026-10-16 19:30

最新新闻

  • 评级变动
    Citi Maintains Privia Health(PRVA.US) With Buy Rating, Maintains Target Price $32
    \u5e02\u573a\u8d44\u8baf · 2026/5/14
  • BTIG Maintains Privia Health(PRVA.US) With Buy Rating, Maintains Target Price $35
    \u5e02\u573a\u8d44\u8baf · 2026/8/10
  • 评级变动
    Citi Maintains Privia Health(PRVA.US) With Buy Rating, Raises Target Price to $35
    \u5e02\u573a\u8d44\u8baf · 2026/7/23
  • 评级变动
    Barclays Maintains Privia Health(PRVA.US) With Hold Rating, Cuts Target Price to $24
    \u5e02\u573a\u8d44\u8baf · 2026/5/26
  • 评级变动
    A Quick Look at Today's Ratings for Privia Health(PRVA.US), With a Forecast Between $26 to $36
    \u5e02\u573a\u8d44\u8baf · 2026/5/8
  • 评级变动
    J.P. Morgan Maintains Privia Health(PRVA.US) With Buy Rating, Raises Target Price to $35
    \u5e02\u573a\u8d44\u8baf · 2026/3/7
  • 评级变动
    CCORF Maintains Privia Health(PRVA.US) With Buy Rating, Maintains Target Price $34
    \u5e02\u573a\u8d44\u8baf · 2026/5/28
  • 评级变动
    Evercore Maintains Privia Health(PRVA.US) With Buy Rating, Cuts Target Price to $26
    \u5e02\u573a\u8d44\u8baf · 2026/4/8
  • 评级变动
    Barclays Maintains Privia Health(PRVA.US) With Hold Rating, Raises Target Price to $25
    \u5e02\u573a\u8d44\u8baf · 2026/3/25
  • 评级变动
    Piper Sandler Maintains Privia Health(PRVA.US) With Buy Rating, Raises Target Price to $36
    \u5e02\u573a\u8d44\u8baf · 2026/3/19
  • Barclays Maintains Privia Health(PRVA.US) With Hold Rating, Maintains Target Price $24
    \u5e02\u573a\u8d44\u8baf · 2026/8/28
  • Truist Financial Maintains Privia Health(PRVA.US) With Buy Rating, Announces Target Price $33
    \u5e02\u573a\u8d44\u8baf · 2026/8/13
  • Citi Maintains Privia Health(PRVA.US) With Buy Rating, Maintains Target Price $35
    \u5e02\u573a\u8d44\u8baf · 2026/8/11
  • 评级变动
    TD Cowen Maintains Privia Health(PRVA.US) With Buy Rating, Maintains Target Price $30
    \u5e02\u573a\u8d44\u8baf · 2026/5/12
  • 评级变动
    Truist Financial Maintains Privia Health(PRVA.US) With Buy Rating
    \u5e02\u573a\u8d44\u8baf · 2026/5/28
  • 评级变动
    CCORF Maintains Privia Health(PRVA.US) With Buy Rating, Maintains Target Price $35
    \u5e02\u573a\u8d44\u8baf · 2026/5/5
  • 评级变动
    Analysts Are Bullish on These Healthcare Stocks: Sionna Therapeutics, Inc. (SION), Privia Health Group (PRVA)
    TipRanks · 2026/3/7
  • 评级变动
    Truist Financial Maintains Privia Health(PRVA.US) With Buy Rating, Cuts Target Price to $21.21
    \u5e02\u573a\u8d44\u8baf · 2026/4/6
  • 评级变动
    RBC Capital Maintains Privia Health(PRVA.US) With Buy Rating, Maintains Target Price $31
    \u5e02\u573a\u8d44\u8baf · 2026/7/9
  • A Quick Look at Today's Ratings for Privia Health(PRVA.US), With a Forecast Between $30 to $36
    \u5e02\u573a\u8d44\u8baf · 2026/8/8

新闻标题为自动聚合内容,未经我们团队独立核实或编辑。

报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

普里维亚健康 讨论区 0 条评论

发表评论